CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38(low/-) precursors

British Journal of Haematology

Volumn 108, Issue 3, 2000, Pages 610-620

  Pierelli, Luca ^a   Scambia, Giovanni ^a   Bonanno, Giuseppina ^a   Rutella, Sergio ^a   Puggioni, Pierluigi ^a   Battaglia, Alessandra ^a   Mozzetti, Simona ^a   Marone, Maria ^a   Menichella, Giacomo ^a   Rumi, Carlo ^a   Mancuso, Salvatore ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autocrine TGF 1; CD105; CD25; Circulating CD34+; Primitive precursors

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; BURST FORMING UNIT; CELL AGGREGATION; CELL CYCLE G0 PHASE; CELL KINETICS; CELL SELECTION; COLONY FORMING UNIT GM; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD;

ADP-RIBOSYL CYCLASE; ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; CELL DIVISION; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; G0 PHASE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; OVARIAN NEOPLASMS; RECEPTORS, CELL SURFACE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0034117227     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01869.x     Document Type: Article

References (35)

1. Cheifetz, S., Bellòn, T., Calès, C., Vera, S., Bernabéu, C., Massaguè, J. & Letarte, M. (1992) Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. Journal of Biological Chemistry, 267, 19027-19030.
2. Craig, W., Kay, R., Cutler, R.L. & Lansdorp, P.M. (1993) Expression of Thy-1 on human haematopoietic progenitor cells. Journal of Experimental Medicine, 177, 1331-1342.
3. Darzynkiewicz, Z., Traganos, F., Sharpless, T. & Melamed, M.R. (1976) Lymphocyte stimulation: a rapid, multiparameter analysis. Proceedings of the National Academy of Sciences of the United States of America, 73, 2881-2884.
4. Di Giusto, D., Chen, S., Webb, S., Namikawa, R., Tsukamoto, A., Chen, B.P. & Galy, A.H. (1994) Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood, 84, 421-432.
5. Fritsch, G., Buchinger, P., Printz, D., Fink, F.M., Mann, G., Peters, C., Wagner, T., Adler, A. & Gadner, H. (1993) Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis. Blood, 81, 2301-2309.
6. Gougos, A. & Letarte, M. (1988) Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. Journal of Immunology, 141, 1925-1933.
7. high cells. Blood, 82, 3283-3289.
8. Hao, Q.-L., Shah, A.J., Thiemann, F.T., Smogorzewska, M.E. & Crooks, G.M. (1995) A functional comparison of CD34+CD38-cells in cord blood and bone marrow. Blood, 86, 3745-3753.
9. Hatzfeld, J., Li, M.-L., Brown, E.L., Sookdeo, H., Levesque, J.-P., O'Toole, T., Gurney, C., Clark, S.C. & Hatzfeld, A. (1991) Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. Journal of Experimental Medicine, 174, 925-929.
10. Hoffman, R. (1989) Regulation of megakaryocytopoiesis. Blood, 74, 1196-1212.
11. Humeau, L., Bardin, F., Maroc, C., Alario, T., Galindo, R., Mannoni, P. & Chabannon, C. (1996) Phenotypic, molecular, and functional characterization of human peripheral blood CD34+/THY1+ cells. Blood, 87, 949-955.
12. Jordan, C.T., Yamasaki, G. & Minamoto, D. (1996) High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Experimental Hematology. 24, 1347-1355.
13. Kessinger, A. & Armitage, J.O. (1991) The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood, 77, 211-213.
14. Korbling, M. & Champlin, R. (1996) Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts. Stem Cells, 14, 185-195.
15. Lansdorp, P.M., Sutherland, H.J. & Eaves, C.J. (1990) Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. Journal of Experimental Medicine, 172, 363-366.
16. Link, H., Arseniev, L., Bahre, O., Kadar, J.G., Diedrich, H. & Poliwoda, H. (1996) Transplantation of allogeneic CD34+ blood cells. Blood, 87, 4903-4909.
17. Miller, J.S., Verfaillie, C. & McGlave, P. (1992) The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture. Blood, 80, 2182-2187.
18. Murray, L., Chen, B., Galy, A., Chen, S., Tushinski, R., Uchida, N., Negrin, R., Tricot, G., Jagannath, S., Vesole, D., Barlogie, B., Hoffman, R. & Tsukamoto, A. (1995) Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin-subpopulation from mobilized peripheral blood. Blood, 85, 368-378.
19. Park, J.R., Bernstein, I.D. & Hockenbery, D.M. (1995) Primitive human hematopoietic precursors express bcl-x but not bcl-2. Blood, 86, 868-876.
20. Pierelli, L., Scambia, G., Menichella, G., Fattorossi, A., Ciarli, A., Bonanno, G., Battaglia, A., d'Onofrio, G., Benedetti Panici, P., Iacone, A., Mancuso, S. & Leone, G. (1997) Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor. British Journal of Haematology, 96, 55-63.
21. Pierelli, L., Scambia, G., Fattorossi, A., Bonanno, G., Battaglia, A., Rumi, C., Marone, M., Mozzetti, S., Rutella, S., Menichella, G., Romeo, V., Mancuso, S. & Leone, G. (1998) Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haematopoietic progenitors. British Journal of Haematology, 102, 1139-1150.
22. Pierelli, L., Perillo, A., Greggi, S., Salerno, G., Benedetti Panici, P., Menichella, G., Fattorossi, A., Leone, G., Mancuso, S. & Scambia, G. (1999a) Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. Journal of Clinical Oncology, 17, 1288-1295.
23. Pierelli, L., Scambia, G., Bonanno, G., Coscarella, A., De Santis, R., Mele, A., Battaglia, A., Fattorossi, A., Romeo, V., Menichella, G., Mancuso, S. & Leone, G. (1999b) Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15. Experimental Hematology, 27, 416-424.
24. Quackenbush, E.J. & Letarte, M. (1985) Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. Journal of Immunology, 134, 1276-1285.
25. Rokhlin, O.W., Cohen, M.B., Kubagawa, H., Letarte, M. & Cooper, M.D. (1995) Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. Journal of Immunology, 154, 4456-4465.
26. Rumi, C., Rutella, S., Teofili, L., Etuk, B., Ortu La Barbera, E., Micciulli, G., Voso, M.T. & Leone, G. (1997) RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression. Experimental Hematology, 25, 246-251.
27. Saeland, S., Duvert, V., Caux, C., Pandrau, D., Favre, C., Vallé, A., Durand, I., Charbord, P., de Vries, J. & Banchereau. J. (1992) Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Experimental Hematology, 20, 24-33.
28. Sakabe, H., Ohmizono, Y., Tanimukai, S., Kimura, T., Mori, K.J., Abe, T. & Sonoda, Y. (1997) Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. Stem Cells, 15, 73-81.
29. Sitnicka, E., Ruscetti, W.F., Priestley, G.V., Wolf, N.S. & Bartelmez, S.H. (1996) Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood, 88, 82-88.
30. Sutherland, H.J., Eaves, C.J., Lansdorp, P.M., Thacker, J.D. & Hogge, D.E. (1991) Differential regulation of primitive hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood, 78, 666-672.
31. Teofili, L., Iovino, M.S., Sica, S., Pierelli, L., Menichella, G., De Stefano, V., Rumi, C. & Leone, G. (1994) Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor. Experimental Hematology, 22, 990-995.
32. Terstappen, L.W.M.M., Huang, S., Safford, D.M., Lansdorp, P.M. & Loken, M.R. (1991) Sequential generations of hematopoietic colonies derived from single nonlineage committed CD34+CD38-progenitor cells. Blood, 77, 1218-1227.
33. Van Ranst, P.C.F., Snoeck, H.-W., Lardon, F., Lenjou, M., Nijs, G., Weekx, S.F.A., Rodrigus, I., Berneman, Z.N. & Van Bockstaele, D.R. (1996) TGF-β and MIP-1α exert their main inhibitory activity on very primitive CD34++CD38-cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors. Experimental Hematology, 24, 1509-1515.
34. Yin, A.H., Miraglia, S., Zanjani, E.D., Almeida-Porada, G., Ogawa, M., Leary, A.G., Olweus, J., Kearney, J. & Buck, D.W. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90, 5002-5012.
35. Yu, H., Fehniger, T.A., Fuchshuber, P., Thiel, K.S., Vivier, E., Carson, W.E. & Caligiuri, M.A. (1998) Flt 3 ligand promotes the generation of a distinct CD34+ human natural killer cell progenitor that responds to interleukin-15. Blood, 92, 3647-3657.